Clinical Trials Directory

Trials / Unknown

UnknownNCT03946384

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype

Discrepancy Between Factor IX Level and Bleeding Phenotype

Status
Unknown
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

It appears that the mutation p.Ile112Thr in the factor IX gene confers a discrepancy between mild factor IX level and severe bleeding phenotype. Databases and litterature analysis are poor on this matter. The goal of this study is to compile bleeding phenotype in patients with this specific mutation to prove the clinico-biological discordance in order to improve patient care and follow-up.

Conditions

Interventions

TypeNameDescription
OTHERdata collectiondata collection on the history of the disease, hemophilia

Timeline

Start date
2019-06-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2019-05-10
Last updated
2019-05-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03946384. Inclusion in this directory is not an endorsement.